Vibegron

Another Name
vibegron 维贝格龙 GEMTESA
Indications
Treat overactive bladder
Reg No
07 L 1140 /24
Inspection No
1459-24
dosage form:Tablets
Specs:75mg * 30 Tablets
Indate:2 Years
Date:2024-9-1 Views:1300

COMPOSITION:

Each film-coated tablet contains Vibegron ………………………………..75mg.

INDICATION:

LuciVibe is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.

DOSAGE AND USE:

• The recommended dose is one 75 mg tablet once daily.

• Swallow tablet whole with water.

• Tablet may be crushed and mixed with applesauce.

STORAGE:

In a dry place and store at 20°C to 25°C.

MANUFACTURED AND MARKETED BY:

LUCIUS PHARMACEUTICALS(LAO) CO., LTD

No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING:

Keep medicine out of reach of Children. Do not administer LuciVibe during Pregnancy and Lactation.

Original article, if reprinted, please indicate the link to this article: https://lucius-pharmaceuticals.com/drug/vibegron/

Related News